Akcea Therapeutics is biopharmaceutical company developing and marketing drugs globally to treat patients with rare and serious diseases. The company's TEGSEDI treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. The company is also focused on commercial preparations for WAYLIVRA in the European Union. WAYLIVRA is an adjunct to diet in adult patients with genetically confirmed familial chylomicronemia syndrome, who are at risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. TEGSEDI, WAYLIVRA and its pipeline drugs are based on the company's antisense technology platform.

ANGI Homeservices connects homeowners to home service professionals through its portfolio of digital home services brands. The company has two segments: North America (United States and Canada), which includes HomeAdvisor digital marketplace service (HomeAdvisor), Angie's List, its subsidiary, Handy Technologies, Inc. (Handy), mHelpDesk and HomeStars; and Europe, which includes Travaux, MyHammer, My Builder, Werkspot and Instapro. HomeAdvisor provides consumers with tools and resources to help them find local, pre-screened and customer-rated service professionals, as well as book appointments online. Handy connects individuals looking for household services with pre-screened service professionals.

Aramark is a provider of food, facilities and uniform services. The company manages its Food and Support Services (FSS) business in segments split between its United States and International operations. The company's FSS segments manage a number of interrelated services-including food, hospitality, procurement and facility services-for school districts, colleges and universities, healthcare facilities, businesses, sports, entertainment and recreational venues, conference and convention centers, national and state parks and correctional institutions. The company's Uniform and Career Apparel segment provides employee uniform solution, including design, sourcing and manufacturing, delivery, cleaning and maintenance.

Assured Guaranty is a Bermuda-based holding company that provides, through its operating subsidiaries, credit protection products to the U.S. and international public finance including infrastructure and structured finance markets. The company markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities as well as to investors in such obligations. The company guarantees obligations issued in the U.S. and the U.K, and also guarantees obligations issued in other countries and regions. The company's financial guaranty direct and assumed businesses provide credit protection on public finance, infrastructure and structured finance obligations.

Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company has three platforms: its Oncology Innovation Platform, dedicated to the research and development of its proprietary drugs; its Commercial Platform, focused on the sales and marketing of its specialty drugs and the market development of its proprietary drugs; and its Global Supply Chain Platform, dedicated to providing a supply of active pharmaceutical ingredients for its clinical and commercial efforts. The company's clinical pipeline includes: Orascovery, Src Kinase inhibition, T-cell Receptor-engineered T-cells, and arginine deprivation therapy.

Cannae is a holding company engaged in managing and operating a group of companies and investments. The company's segments are: Restaurant Group, which consists of the operations of American Blue Ribbon Holdings, LLC and 99 Restaurants Holdings, LLC; Ceridian, which consists of the operations of the company's subsidiary, Ceridian HCM Holding, Inc., a global human capital management software company; T-System, which consists of the operations of the company's subsidiary, T-System Holdings, LLC, a provider of clinical documentation and coding solutions; and Corporate and Other, which consists of the company's share in the operations of controlled and uncontrolled portfolio companies.

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. The company has licensed the North American rights to Firdapse?, a proprietary form of amifampridine phosphate, or chemically known as 3,4-diaminopyridine phosphate, from BioMarin Pharmaceutical Inc. for the treatment of patients with Lambert-Eaton Myasthenic Syndrome, Congenital Myasthenic Syndromes and Myasthenia Gravis. In addition, the company has launched Firdapse? in the United States, selling through a field force in neurologic, central nervous system or rare disease products consisting of field personnel.

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

Cerus is a biomedical products company focused on developing and commercializing the INTERCEPT Blood System for blood safety. The INTERCEPT Blood System, which is based on the company's technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company's INTERCEPT Blood System is for use with three blood components: plasma, platelets, and red blood cells. The platelet system and plasma system are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion and the red blood cell system is designed to inactivate blood-borne pathogens in red blood cells donated for transfusion.

Cidara Therapeutics is a biotechnology company focused on the discovery, development and commercialization of anti-infectives for the treatment and prevention of diseases. The company is developing a pipeline of product and development candidates, with a focus on fungal and infections. The company's primary product candidate is rezafungin acetate, an intravenous formulation of a echinocandin. Rezafungin is being developed as a once-weekly therapy for the first-line treatment and prevention of fungal infections. In addition, the company is using its Cloudbreak? platform to develop Antiviral Fc-Conjugates, for the prevention and treatment of influenza and other infections.

CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company's primary focus is on the development of its key product candidate, Neutrolin

FedEx provides transportation, e-commerce and business services through companies under the FedEx brand. These companies are included in the following segments: Federal Express Corporation, including TNT Express B.V., is an express transportation company; FedEx Ground Package System, Inc., which is a provider of small-package ground delivery services; FedEx Freight Corporation, which is a provider of less-than-truckload freight services; and FedEx Corporate Services, Inc., which provides sales, marketing, information technology, communications, customer service, technical support, billing and collections services, and certain back-office functions.

Five Prime Therapeutics is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The company's key product candidates are: FPA150, which is a CD8 T cell checkpoint inhibitor antibody that targets B7-H4 that it is studying in a clinical trial in multiple cancers; FPT155, which is a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28 that the company is studying in a clinical trial in multiple cancers; and Cabiralizumab (FPA008) is an antibody that the company and its partner Bristol-Myers Squibb Company, or BMS, are studying in clinical trials in multiple cancers in combination with BMS's PD-1 immune checkpoint inhibitor, Opdivo? (nivolumab).

FleetCor Technologies is provider of commercial payment solutions. The company's five primary product lines are Fuel, which provides fuel payment solutions to businesses and government entities who operate vehicle fleets, as well as to main oil companies;Lodging, which provides lodging payment solutions to employees who travel overnight for work purposes; Tolls, which provides an electronic toll and parking payments product; Corporate Payments, which include virtual cards, purchasing cards, travel and entertainment cards; and Gift, which provides gift card product management and processing services. Additionally, the company provides other payment products including fleet maintenance and employee benefits.

Hallador Energy is engaged in the production of steam coal from mines located in western Indiana. The company also owns a 50% interest in Sunrise Energy, LLC, a private gas exploration company with operations in Indiana. Additionally, the company owns 100% of Hourglass Sands, LLC, a frac sand mining company in the State of Colorado.

Heron Therapeutics is a commercial-stage biotechnology company. The company is developing patient-focused solutions that apply its science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. The company develops SUSTOL for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide combination chemotherapy regimens. The company's second commercial product, CINVANTI, is indicated for the prevention of acute and delayed nausea and vomiting associated with of highly emetogenic cancer chemotherapy and nausea and vomiting associated with MEC.

Hersha Hospitality Trust is a real estate investment trust. The company invests primarily in institutional grade hotels in primary urban gateway markets including New York, Washington, District of Columbia, Boston, Philadelphia, South Florida and select markets on the West Coast. The company owns its hotels and its investments in joint ventures through its operating partnership, Hersha Hospitality Limited Partnership, for which the company serves as the sole general partner. The majority of the company's wholly-owned hotels are managed by Hersha Hospitality Management, L.P., a management company owned by certain of its trustees and executive officers and other unaffiliated third party investors.

Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. The Company uses therapeutic vaccines to treat an already existing disease and is thus given to the already sick patients; therapeutic cancer vaccines administered to patients in order to delay or stop tumor cell growth, shrink tumors, prevent relapse, or to kill cancer cells that could not be eliminated with other treatments. The Company has several technology platforms, such as The Combig, Intuvax@, Subcuvax@ and The CD70, among others. The Company has several projects which are related to kidney cancer and liver cancer, among others.

Interface is engaged in the design, production and sales of modular carpet, also known as carpet tile. The company's modular carpet system, which is marketed under the brands Interface and FLOR, utilizes carpet tiles cut in squares or rectangles to produce a floorcovering. The company's GlasBac? technology employs a fiberglass-reinforced polymeric composite backing that provides dimensional stability and reduces the need for adhesives or fasteners. In addition to general uses of its carpet tile, the company produces and sells an adapted version of its carpet tile for the healthcare facilities market. Furthermore, the company also sells an antimicrobial chemical compound under the registered trademark Intersept.

KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The company's product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME). The company has a portfolio of oral plasma kallikrein inhibitors and developed various drug candidates into clinical trials in order to create oral therapies for both HAE and DME. The company has initiated a clinical study of KVD900 as a therapy for acute HAE attacks. The company has also commenced a clinical trial of KVD001, its DME drug candidate.

New Mountain Finance is a closed-end, non-diversified management investment company that is engaged in the sourcing and origination of debt securities at various levels of the capital structure, including first and second lien debt, notes, bonds and mezzanine securities. In some cases, the company's investments may also include equity interests. The company makes investments through both primary originations and open-market secondary purchases.

Occidental Petroleum has three reporting segments: oil and gas, which explores for, develops and produces oil and condensate, natural gas liquids (NGL) and natural gas; chemical, which mainly manufactures and markets basic chemicals (chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates and calcium chloride) and vinyls (vinyl chloride monomer, polyvinyl chloride and ethylene); and marketing and midstream, which purchases, markets, gathers, processes, transports and stores oil, condensate, NGL, natural gas, carbon dioxide and power.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Performant Financial provides echnology-enabled audit, recovery, outsource customer services, and related analytics services. The company's services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments. The company generally provides its services on an outsourced basis, where the company handles various aspects of its clients' recovery processes. The company uses its technology-enabled services platform to provide recovery and analytics services in a range of markets for the identification and recovery of student loans, improper healthcare payments and delinquent state and federal tax and federal treasury receivables.

Principia Biopharma is a late-stage biopharmaceutical company. The company has produced three new drug candidates from its platform. The company's key drug candidate, PRN1008, is designed to form a reversible covalent bond with the Bruton's Tyrosine Kinase (BTK) enzyme. The second drug candidate in the company's BTK franchise is PRN2246/SAR442168, an irreversible covalent BTK inhibitor that it designed to cross the blood-brain barrier and modulate immune cell function in the brain for the treatment of multiple sclerosis, and potentially other central nervous system. PRN1371, an additional wholly owned drug candidate, is an inhibitor of Fibroblast Growth Factor Receptor designed for the treatment of solid tumors.

Provention Bio is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company's principal product candidates include: PRV-031 (teplizumab, anti-CD3 mAb) for the interception of type 1 diabetes; PRV-015 (anti-IL-15 mAb) for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 (oral CSF-1R inhibitor) for the treatment of Crohn's disease; PRV-300 (anti-TLR3 mAb) for the treatment of ulcerative colitis; and PRV-3279 (humanized anti-CD32B and CD79B bispecific) for the treatment of lupus.

Retail Opportunity Investments is a self-managed real estate investment trust. The company is engaged in the acquisition, ownership and management of necessity-based community and neighborhood shopping centers on the west coast of the U.S., anchored by supermarkets and drugstores. The company focuses on leasing to retailers that provide necessity-based, non-discretionary goods and services, catering to the basic and daily needs of the surrounding community. The company conducts substantially all of its business through its operating partnership, Retail Opportunity Investments Partnership, LP, a limited partnership, together with its subsidiaries.

Rhythm Pharmaceuticals is a biopharmaceutical company. The company's primary product candidate is setmelanotide, which is a melanocortin-4 (MC4) receptor agonist peptide for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. MC4 pathway deficiencies result in the disruption of satiety signals and energy homeostasis in the body, which, in turn, leads to intense feelings of hunger and to obesity. The company is evaluating setmelanotide for the treatment of six single gene related MC4 pathway deficiencies: pro-opiomelanocortin (POMC), leptin receptor, Bardet-Biedl syndrome, Alstrom syndrome, POMC heterozygous, and POMC epigenetic disorders.

Roadrunner Transportation Systems is an asset-light transportation and logistics service provider. The company has three segments: Truckload Logistics (TL), which arranges the pickup and delivery of truckload, intermodal, and ground and air expedited freight throughout the U.S., Mexico and Canada; Less-than-Truckload (LTL), which involves the pickup, consolidation, linehaul, deconsolidation, and delivery of LTL shipments throughout the U.S. and parts of Canada; and Ascent Global Logistics, which provides a domestic and international transportation and logistics solution, with offering that includes contract management, transportation mode and carrier selection, freight tracking and dispatch.

Sequential Brands Group is a licensing and brand management company. The company owns consumer brands in the home, active and fashion categories, including Martha Stewart, Jessica Simpson, AND1, Avia, Joe's and GAIAM. The company has license agreements with partners that are responsible for manufacturing and distributing its licensed products and primarily responsible for the design of such licensed products. The company's brands are licensed for a range of product categories, including apparel, footwear, fashion accessories and home goods, as well as, with respect to its Martha Stewart brand, food, wine and a variety of media related assets, such as magazines, books and other print and digital content.

Stage Stores is a retailer, which operates specialty department stores and off-price stores. The company provides apparel, accessories, cosmetics, footwear and home goods. The company also operates an e-commerce website for its department store business. The company's department stores are predominantly located in small towns and rural communities. The company's off-price stores are predominantly located in mid-sized, non-rural Midwest markets. The company provides merchandise within merchandise categories of women's, men's and children's apparel, accessories, cosmetics, footwear and home goods that reflect existing styles and trends through its department stores, off-price stores and e-commerce website.

Streamline Health Solutions is a provider of solutions and services for healthcare providers throughout the U.S. and Canada. The company provides computer software-based solutions and auditing services, which capture, aggregate and translate structured and unstructured data to deliver organized, accessible predictive insights to its clients. The company provides solutions and services to assist its clients in revenue cycle management including Coding and Clinical Documentation Improvement, Health Information Management, Financial Management and eValuator?, its solution which delivers automated coding analysis prior to billing.

Tailored Brands is a retailer of men's tailored clothing and men's formalwear provider in the U.S. and Canada. The company's operations are conducted in two segments: retail, which provides the company's products and services primarily through the company's retail brands - Men's Wearhouse, Men's Wearhouse and Tux, Jos. A. Bank Clothiers, Moores, Joseph Abboud, and K&G - and the internet at www.menswearhouse.com, www.josbank.com, and www.josephabboud.com; and corporate apparel, which includes the activities from the company's corporate apparel and uniform operations conducted by Dimensions, Alexandra and Yaffy in the U.K. and Twin Hill in the U.S., which provide corporate apparel uniforms and workwear to workforces.

Tenet Healthcare is a healthcare services company. Through its subsidiaries, partnerships and joint ventures, including USPI Holding Company, Inc., the company operates hospitals, surgical hospitals and outpatient centers. In addition, the company's Conifer Holdings, Inc. (Conifer) subsidiary provides healthcare business process services in the areas of hospital and physician revenue cycle management and care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company has three reportable segments: Hospital Operations and other; Ambulatory Care; and Conifer.

TerraForm Power is a holding company and its only material asset is an equity interest in TerraForm Power, LLC, which through its subsidiaries owns and operates renewable energy facilities that have long-term contractual arrangements to sell the electricity generated by these facilities to third parties. The related green energy certificates, ancillary services and other environmental attributes generated by these facilities are also sold to third parties. The company's portfolio consists of renewable energy facilities located in the United States (including Puerto Rico), Canada, Spain, Chile, Portugal, the United Kingdom and Uruguay.

Thor Industries is a manufacturer of recreational vehicles. The company has three segments: North American Towable Recreational Vehicles, which consists of: Airstream (towable), Heartland (including Bison, Cruiser RV and DRV), Jayco (including Jayco towable, Starcraft and Highland Ridge), Keystone (including CrossRoads and Dutchmen) and KZ (including Venture RV); North American Motorized Recreational Vehicle, which consists of: Airstream (motorized), Jayco (including Jayco motorized and Entegra Coach) and Thor Motor Coach; and European Recreational Vehicles, which consists of the Erwin Hymer Group business.

Tile Shop Holdings is a holding company. Through its subsidiaries, the company is a retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the U.S. The company provides a range of natural stone and man-made tile products, sourced directly from its suppliers. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, and metal tiles. The company's accessories, including trim pieces, mosaics, pencils, listellos, and other products. The company also provides a range of setting and maintenance materials, such as thinset, grout, sealers, and accessories.

Ulta Beauty is a beauty retailer that provides cosmetics, fragrance, skin care products, hair care products, and salon services. The company's stores are primarily located in locations such as power centers. The company provides a range of services in all of its stores. The company's stores, website, and mobile applications provides more than 25,000 products from approximately 500 beauty brands across all categories and price points, including its own private label, the Ulta Beauty Collection. The company provides a portfolio across five primary categories: cosmetics; skincare, bath and fragrance; haircare products and styling tools; salon services; and other, which includes nail products and accessories.

United Natural Foods is a distributor of natural, organic, specialty, produce, and grocery and non-food products, and provider of support services in the United States and Canada. The company's selection of products includes nationally advertised brand name and private-label products, including grocery, general merchandise, home, health and beauty care, and pharmacy, which are sold through its Wholesale segment to wholesale customers and through its subsidiary, SUPERVALU INC.'s-operated retail stores to shoppers. The company provides marketing services for its customers and suppliers, including consumer and trade marketing programs, as well as programs to support suppliers in understanding its markets.

USA Technologies is a provider of solutions, including wireless networking, cashless transactions, asset monitoring and other services that facilitate electronic payment transactions primarily within the unattended point of sale market. The company is a provider in the small ticket beverage and food vending industry and is expanding its solutions and services in other unattended market segments. The company has designed and marketed systems and solutions that facilitate electronic payment options, as well as telemetry and Internet of Things services, which include the ability to remotely monitor, control, and report on the results of distributed assets containing its electronic payment solutions.

WesBanco is a bank holding company. Through its subsidiaries, the company provides a range of financial services including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking and insurance. The company operates two segments: community banking, which provides services provided by commercial banks, including commercial demand, individual demand and time deposit accounts, as well as commercial, mortgage and individual installment loans, and certain non-traditional offerings; and trust and investment services, which provides trust services as well as various alternative investment products including mutual funds.

Workday is a provider of enterprise cloud applications for finance and human resources. The company's products include: Workday Financial Management, an application with financial capabilities, analytics and metrics, and auditable process management; and Workday Human Capital Management, which includes global human resources management (workforce lifecycle management, organization management, compensation, absence, and employee benefits administration) and global talent management (goal management, performance management, succession planning, and career and development planning). The company's other solutions include Adaptive Insights Business Planning Cloud, as well as Workday Data-as-a-Service.